drugset / Trial / NCT03340896

Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT

NCT03340896 ↗

Phase 3 Active not recruiting 256 enrolled Groupe Oncologie Radiotherapie Tete et Cou
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compare the survival without laryngeal dysfunction 2 years after the end of treatment, obtained by chemotherapy followed by radiotherapy or chemotherapy with cisplatin administrated during radiotherapy.

Timeline

Start
2015-06-25
Primary completion
2028-10
Completion
2028-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Cisplatin Other / unclassified 100 mg/m2 Intravenous
Comparator Docetaxel Small molecule 75 mg/m2 Intravenous
Comparator fluorouracil Small molecule 750 mg/m2 —